Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
India
/
Pharmaceuticals & Biotech
Create a narrative
J. B. Chemicals & Pharmaceuticals Community
BSE:506943 Community
1
Narratives
written by author
0
Comments
on narratives written by author
5
Fair Values set
on narratives written by author
Community Investing Ideas
J. B. Chemicals & Pharmaceuticals
Popular
Undervalued
Overvalued
J. B. Chemicals & Pharmaceuticals
AN
AnalystConsensusTarget
Consensus Narrative from 12 Analysts
Chronic Therapeutic Demand And CDMO Launches Will Extend Global Reach
Key Takeaways Expansion in international markets and growth of both legacy and acquired brands support revenue stability and improve long-term earnings visibility. Cost optimization and product mix shifts drive margin improvements, while strong performance in chronic and acute segments ensures sustained outperformance.
View narrative
₹2.02k
FV
15.0% undervalued
intrinsic discount
12.16%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
7 days ago
author updated this narrative
Your Valuation for
506943
506943
J. B. Chemicals & Pharmaceuticals
Your Fair Value
₹
Current Price
₹1.72k
6.6% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
70b
2015
2018
2021
2024
2025
2027
2030
Revenue ₹69.6b
Earnings ₹11.9b
Advanced
Set Fair Value